Литература

1. Hong G. W., Hu H., Chang K., Park Y., et al. Review of the adverse effects associated with dermal filler treatments: part I nodules, granuloma, and migration. Diagnostics (Basel). 2024, № 14(15): 1640.
2. Humphrey S., Jones D. H., Carruthers J. D., Carruthers A., et al. Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/ml hyaluronic acid filler in 4 500 patients. J Am Acad Dermatol. 2020, № 83(1): 86-95.
3. Wojtkiewicz M., Stachura A., Roszkowski B. et al. Are we overlooking harms of BDDE-cross-linked dermal fillers? A scoping review. Aesth Plast Surg. 2024, № 48: 5147–5154.
4. Kim D. H., Jeong C. H., Han J. H., Lim S. J., et al. Comparative toxicity study of hyaluronic acid fillers crosslinked with 1,4-butanediol diglycidyl ether or poly (ethylene glycol) diglycidyl ether. Int J Biol Macromol. 2025, № 296: 139620.
5. Wollina U., Goldman A., Kocic H., Andjelkovic T., et al. Impurities in hyaluronic acid dermal fillers? A narrative review on nonanimal cross-linked fillers. Facial Plast Surg Aesthet Med. 2024, № 26(2): 190-194.
6. Artzi O., Cohen J. L., Dover J. S., Suwanchinda A., et al. Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm. Clin Cosmet Investig Dermatol. 2020, № 13: 371-378.
7. Kim M., De R., Cho D. C. et al. Effect of cross-linker chain length on biophysical property of hyaluronic acid hydrogel dermal filler. Macromol. Res. 2023, № 31: 843–850.
8. Клиническая апробация по теме: «Оценка эффективности и безопасности внутрикожного введения филлера на основе гиалуроновой кислоты с использованием патоморфологических методов исследования» на базе ФГБУ ДПО «ЦГМА», 2024 г.